Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden · Delayed Price · Currency is SEK 2.600
+0.110 (4.42%)
Jul 24, 2026, 5:23 PM CET
STO:NEWBRY Income Statement
Financials in millions SEK. Fiscal year is September - August.
Millions SEK. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
| 36.63 | 34.21 | 39.74 | 11.17 | 7.24 | 2.84 | |
Revenue Growth (YoY) | -26.31% | -13.91% | 255.77% | 54.27% | 154.93% | - |
Cost of Revenue | 25.4 | 18.74 | 20.8 | 6.32 | 3.95 | 2.37 |
Gross Profit | 11.23 | 15.46 | 18.94 | 4.85 | 3.29 | 0.47 |
Selling, General & Admin | 28.25 | 27.77 | 28.77 | 20.81 | 14.66 | 5.46 |
Depreciation & Amortization Expenses | 5.74 | 5.67 | 1.74 | 1.26 | 1.01 | 0.61 |
Other Operating Expenses | 2.03 | 3.99 | 2.51 | 2.37 | 2.29 | 0.03 |
Total Operating Expenses | 36.02 | 37.43 | 33.02 | 24.44 | 17.96 | 6.09 |
Operating Income | -24.79 | -21.97 | -14.08 | -19.59 | -14.67 | -5.62 |
Total Non-Operating Income (Expense) | -1.84 | -1.64 | -1.33 | 0.16 | 0 | 0.06 |
Pretax Income | -26.63 | -23.6 | -15.41 | -19.43 | -14.67 | -5.56 |
Provision for Income Taxes | -0.29 | -0.28 | 0 | 0 | 0 | 0 |
Net Income | -26.34 | -23.32 | -15.41 | -19.43 | -14.67 | -5.56 |
Net Income to Common | -26.91 | -23.88 | -15.41 | -19.43 | -14.67 | -5.56 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 30 | 26 | 21 | 20 | 18 | 13 |
Shares Outstanding (Diluted) | 34 | 31 | 25 | 20 | 20 | 16 |
Shares Change (YoY) | 33.53% | 25.40% | 24.39% | 0.60% | 25.19% | - |
EPS (Basic) | -0.89 | -0.92 | -0.72 | -1.00 | -0.82 | -0.42 |
EPS (Diluted) | -0.80 | -0.78 | -0.63 | -0.98 | -0.75 | -0.35 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -19.58 | -12.37 | -23.71 | -23.23 | -15 | -4.07 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.58 | -0.40 | -0.97 | -1.18 | -0.76 | -0.26 |
Gross Margin | 30.66% | 45.20% | 47.66% | 43.43% | 45.41% | 16.58% |
Operating Margin | -67.66% | -64.21% | -35.43% | -175.37% | -202.58% | -197.92% |
Profit Margin | -71.90% | -68.18% | -38.79% | -173.97% | -202.58% | -195.67% |
FCF Margin | -53.45% | -36.16% | -59.66% | -207.96% | -207.20% | -143.17% |
EBITDA | -24.79 | -21.97 | -14.08 | -19.59 | -14.67 | -5.62 |
EBIT | -24.79 | -21.97 | -14.08 | -19.59 | -14.67 | -5.62 |
EBIT Margin | -67.66% | -64.21% | -35.43% | -175.37% | -202.58% | -197.92% |
Effective Tax Rate | 1.08% | 1.19% | -0.03% | 0.00% | 0.00% | 0.00% |